Others have demonstrated the practicality of this approach for delivering certain chemotherapies [241], and as we discuss below, USMB is also being explored as an alternative mode of delivering PD-1/PD-L1 ICIs in cancer patients. The gene discussed is CD274; the disease is cancer.